| Cathelicidins: Immunomodulatory Antimicrobials |
42 |
| A Comparison of Plasmid DNA and mRNA as Vaccine Technologies |
41 |
| Immune History and Influenza Vaccine Effectiveness |
27 |
| Exosomes, Their Biogenesis and Role in Inter-Cellular Communication, Tumor Microenvironment and Cancer Immunotherapy |
25 |
| The Role of Extracellular Vesicles in Viral Infection and Transmission |
25 |
| Efforts to Improve the Seasonal Influenza Vaccine |
21 |
| Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress |
19 |
| Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine |
19 |
| DNA-Protein Vaccination Strategy Does Not Protect from Challenge with African Swine Fever Virus Armenia 2007 Strain |
18 |
| Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System |
17 |
| Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies |
14 |
| Human Cytomegalovirus Cell Tropism and Host Cell Receptors |
14 |
| Radiation as an In Situ Auto-Vaccination: Current Perspectives and Challenges |
14 |
| Meningococcal Vaccines: Current Status and Emerging Strategies |
14 |
| Prevention of Cervical Cancer in Sub-Saharan Africa: The Advantages and Challenges of HPV Vaccination |
12 |
| Subunit Vaccine Approaches for African Swine Fever Virus |
11 |
| New Kids on the Block: RNA-Based Influenza Virus Vaccines |
11 |
| The Immunomodulatory and Antimicrobial Properties of the Vertebrate Ribonuclease A Superfamily |
10 |
| Clinical Trials and Administration of Zika Virus Vaccine in Pregnant Women: Lessons (that Should Have Been) Learned from Excluding Immunization with the Ebola Vaccine during Pregnancy and Lactation |
10 |
| Immunoinformatics-Aided Design and Evaluation of a Potential Multi-Epitope Vaccine against Klebsiella Pneumoniae |
10 |
| A Live-Attenuated Prime, Inactivated Boost Vaccination Strategy with Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccines Provides Protection in Ferrets: A Confirmatory Study |
10 |
| Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection |
10 |
| Recent Advances in the Development of Peptide Vaccines and Their Delivery Systems against Group A Streptococcus |
10 |
| Advances in RNA Vaccines for Preventive Indications: A Case Study of a Vaccine against Rabies |
10 |
| Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays? |
9 |
| Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B |
9 |
| Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study |
9 |
| Novel Whole-Cell Inactivated Neisseria Gonorrhoeae Microparticles as Vaccine Formulation in Microneedle-Based Transdermal Immunization |
9 |
| Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins |
9 |
| Type of RNA Packed in VLPs Impacts IgG Class Switching-Implications for an Influenza Vaccine Design |
8 |
| A Chimeric Zika Virus between Viral Strains MR766 and BeH819015 Highlights a Role for E-glycan Loop in Antibody-mediated Virus Neutralization |
8 |
| Novel Protein-Based Pneumococcal Vaccines: Assessing the Use of Distinct Protein Fragments Instead of Full-Length Proteins as Vaccine Antigens |
8 |
| The Emerging Role of Pattern Recognition Receptors in the Pathogenesis of Malaria |
7 |
| Repurposing Plant Virus Nanoparticles |
7 |
| Virus-Like-Vaccines against HIV |
7 |
| Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD- CTLA- TIM-3 and LAG-3 Immune Checkpoints in CD4(+) T Cells |
7 |
| Historical H1N1 Influenza Virus Imprinting Increases Vaccine Protection by Influencing the Activity and Sustained Production of Antibodies Elicited at Vaccination in Ferrets |
7 |
| In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice |
7 |
| The Role of Fc Gamma Receptors in Broad Protection against Influenza Viruses |
7 |
| Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice |
7 |
| Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy |
7 |
| Zika Virus Vaccines: Challenges and Perspectives |
7 |
| Immunization Status against Measles of Health-Care Workers Operating at Three Sicilian University Hospitals: An Observational Study |
7 |
| Success and Limitation of Equine Influenza Vaccination: The First Incursion in a Decade of a Florida Clade 1 Equine Influenza Virus that Shakes Protection Despite High Vaccine Coverage |
7 |
| Predictors and Barriers to Full Vaccination among Children in Ethiopia |
6 |
| T-Cell Response to Viral Hemorrhagic Fevers |
6 |
| The Future of Influenza Vaccines: A Historical and Clinical Perspective |
6 |
| A GFP Reporter MR766-Based Flow Cytometry Neutralization Test for Rapid Detection of Zika Virus-Neutralizing Antibodies in Serum Specimens |
6 |
| Postgenomic Approaches and Bioinformatics Tools to Advance the Development of Vaccines against Bacteria of the Burkholderia cepacia Complex |
6 |
| From Vaccine Vector to Oncomodulation: Understanding the Complex Interplay between CMV and Cancer |
6 |
